Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01868022 |
| Title | Study to Evaluate GSK3052230 in Combination With Paclitaxel and Carboplatin, or Docetaxel or as Single Agent in Subjects With Solid Malignancies and Deregulated Fibroblast Growth Factor (FGF) Pathway Signaling |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | NLD | GBR | ESP | DNK | BEL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Duarte | California | 91010 | United States | Details | |
| GSK Investigational Site | Sacramento | California | 95817 | United States | Details | |
| GSK Investigational Site | Chicago | Illinois | 60637 | United States | Details | |
| GSK Investigational Site | Peoria | Illinois | 61615-7822 | United States | Details | |
| GSK Investigational Site | Detroit | Michigan | 48201 | United States | Details | |
| GSK Investigational Site | Saint Louis | Missouri | 63110 | United States | Details | |
| GSK Investigational Site | New York | New York | 10065 | United States | Details | |
| GSK Investigational Site | Chapel Hill | North Carolina | 27599-7600 | United States | Details | |
| GSK Investigational Site | Columbus | Ohio | 43210 | United States | Details | |
| GSK Investigational Site | Charleston | South Carolina | 29425 | United States | Details | |
| GSK Investigational Site | Leuven | 3000 | Belgium | Details | ||
| GSK Investigational Site | Koebenhavn Oe | 2100 | Denmark | Details | ||
| GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
| GSK Investigational Site | Arkhangelsk | 163045 | Russian Federation | Details | ||
| GSK Investigational Site | Ryazan | 390011 | Russian Federation | Details | ||
| GSK Investigational Site | St. Petersburg | 197 089 | Russian Federation | Details | ||
| GSK Investigational Site | St. Petersburg | 197758 | Russian Federation | Details | ||
| GSK Investigational Site | St. Petersburg | 198255 | Russian Federation | Details | ||
| GSK Investigational Site | Vsevolozhsk | 188663 | Russian Federation | Details | ||
| GSK Investigational Site | Badajoz | 06080 | Spain | Details | ||
| GSK Investigational Site | Barcelona | 08028 | Spain | Details | ||
| GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28034 | Spain | Details | ||
| GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
| GSK Investigational Site | Málaga | 29010 | Spain | Details | ||
| GSK Investigational Site | Sevilla | 41013 | Spain | Details | ||
| GSK Investigational Site | Leicester | Leicestershire | LE1 5WW | United Kingdom | Details | |
| GSK Investigational Site | London | SE1 9RT | United Kingdom | Details | ||
| GSK Investigational Site | Nottingham | NG5 1PB | United Kingdom | Details |